NEW YORK ( TheStreet) -- Bio-Reference Labs (Nasdaq: BRLI) is trading at unusually high volume Tuesday with 1.2 million shares changing hands. It is currently at 4.1 times its average daily volume and trading up 85 cents (+5.3%) at $16.85 as of 2:09 p.m. ET.

Bio-Reference has a market cap of $450.3 million and is part of the health care sector and health services industry. Shares are down 27.4% year to date as of the close of trading on Monday.

Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases primarily in the greater New York metropolitan area. The company has a P/E ratio of 13.1, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Bio-Reference as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. You can view the full Bio-Reference Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVUP to 95370 or select from multiple alert options.

null